Article Details

Preclinical results show mRNA-based treatment effective against scarring from PVR

Retrieved on: 2024-12-01 14:21:40

Tags for this article:

Click the tags to see associated articles and topics

Preclinical results show mRNA-based treatment effective against scarring from PVR. View article details on hiswai:

Summary

The article discusses a study by the Schepens Eye Research Institute exploring mRNA-based therapy, focusing on RUNX1 to treat retinal diseases like proliferative vitreoretinopathy and macular degeneration. This showcases biopharma's potential in ocular gene expression applications.

Article found on: www.modernretina.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up